LecT-Hepa facilitates estimating treatment outcome during interferon therapy in chronic hepatitis C patients

BACKGROUND: A combination treatment of interferon and ribavirin is the standard and the commonly used treatment for chronic hepatitis C (CHC). Developing noninvasive tests like serum indicators that can predict treatment outcome at an early stage of therapy is beneficial for individualized treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Zou, Xia, Chi, Xiumei, Pan, Yu, Du, Dongning, Sun, Haibo, Matsuda, Atsushi, Li, Wei, Kuno, Atsushi, Zhang, Xinxin, Narimatsu, Hisashi, Niu, Junqi, Zhang, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4276098/
https://www.ncbi.nlm.nih.gov/pubmed/25593566
http://dx.doi.org/10.1186/1559-0275-11-44

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4276098/
https://www.ncbi.nlm.nih.gov/pubmed/25593566
http://dx.doi.org/10.1186/1559-0275-11-44

Ejemplares similares